The beneficial effect of high dose chemotherapy with HSCT in patients with advanced ovarian carcinoma, with complete clinical remission
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 5
Abstract
Twenty-two patients with advanced ovarian carcinoma underwent high-dose chemotherapy supported by hematopoietic stem cell transplantation. Ten patients received double transplantation following ICE and CME, respectively. Twelve patients received only one course of high dose chemotherapy (CME, ICE, Melphalan and Carboplatine or Melphalan). Seven and 15 patients were in CR and PR prior to autologous HSCT, respectively. Toxicity was in a majority of cases manageable. One patient died due to infection complication after the second transplant. All patients were followed and their fate registered. It was shown that patients in clinical remission prior to HD chemotherapy enjoyed statistically significant better two years survival as compared to those with PR (83% vs 37%, p=0.049). The median follow-up of patients was 24.7 months in the CR group and 12.5 months in PR group. Overall cumulative proportion of survival was significantly better in the group with CR prior to the procedure. There was no difference in overall survival with respect to one or two HD chemotherapy courses and to length of the disease. The survival of patients with PR was unsatisfactory calling for a maintenance involving immunotherapy according to the recent progress in this field.
Authors and Affiliations
Andrzej Lange, Joanna Werkun, Dorota Dłubek, Cezary Juda, Marian Gryboś
Keywords
Related Articles
- EP ID EP159824
- DOI -
- Views 78
- Downloads 0
The role of hormone replacement therapy and the risk of development of ovarian cancer
Hormone replacement therapy (HRT), which is mainly used to relieve climacteric symptoms, increases a woman’s risk for breast cancer, uterine endometrial cancer, but the association with ovarian cancer is less clear. Base...
VEGFR-2-receptor - target for anticancer therapy
Vascular endothelial growth factor (VEGF) is a potent mitogen that plays a key role in the growth and maintenance of vascular endothelial cells as well as in the development of new physiological and tumour blood vessels....
Treatment of advanced invasive Thymomas in experience of Oncology Department at Regional Centre of Lung Diseases in Poznań and Department of Thoracic Surgery, Poznań University of Medical Sciences
Introduction: Thymoma is a rare neoplasm, deriving from epithelial tissue of Thymus. ADOC, PAC, PE and VIP are most frequently used combintions. Materials and method: Retrospective analysis including 13 patients treated...
The activity of N-acetyl-β-glucosaminidase and its isoenzymes in the renal tissue, serum and urine of patients with renal cancer
Renal cancer makes up around 3-4% of human neoplasms. It may metastasise, infiltrate and colonise other tissues. Infiltration and metastasis may depend on changes in the oligosaccharide structures of glycoconjugates of t...
Registering the procedure of scintigraphy research of animals in nuclear medicine
A rapid development of veterinary nuclear medicine has taken place in the last decades. It is mostly widespread in the USA and also develops dynamically in western countries, especially in Germany; in central Europe, acc...